<DOC>
	<DOCNO>NCT00006361</DOCNO>
	<brief_summary>RATIONALE : SU5416 may stop growth cancer cell stop blood flow tumor . PURPOSE : Phase II trial study effectiveness SU5416 treat patient advanced recurrent cancer head neck .</brief_summary>
	<brief_title>SU5416 Treating Patients With Advanced Recurrent Cancer Head Neck</brief_title>
	<detailed_description>OBJECTIVES : - Determine effect SU5416 survival tumor response patient advance recurrent squamous cell carcinoma head neck . - Determine safety toxicity SU5416 patient . OUTLINE : Patients receive SU5416 IV 1 hour twice weekly . Treatment continue absence disease progression unacceptable toxicity . Patients follow 1 year . PROJECTED ACCRUAL : A total 35 patient accrue study within 1.4 year .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Skin Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Unknown Primary</mesh_term>
	<mesh_term>Semaxinib</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven epidermoid/squamous cell carcinoma oral cavity , lip , hypopharynx , oropharynx , nasopharynx , sinonasal tract , larynx ; undifferentiated carcinoma nasopharynx ( WHO type III ) ; sinonasal undifferentiated carcinoma ; squamous cell carcinoma unknown primary skin initial presentation head neck region Advanced recurrent disease incurable surgery radiotherapy No 2 prior cytotoxic chemotherapy regimens recurrent , persistent , metastatic disease Prior exposure chemopreventive agent ( e.g. , tretinoin vitamin analogue ) consider prior cytotoxic chemotherapy exposure At least 1 measurable indicator lesion Bone metastases , elevate enzyme level , lesion radionuclide scan acceptable sole parameter measurable disease No history brain metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 60100 % Life expectancy : Not specify Hematopoietic : WBC great 3,000/mm3 Hemoglobin great 8 g/dL Platelet count great 100,000/mm3 No history coagulation disorder Hepatic : Bilirubin normal SGOT le 2.5 time upper limit normal PT great 14 second aPTT great 40 second Renal : Creatinine le 1.5 mg/dL OR Creatinine clearance least 60 mL/min Cardiovascular : No uncompensated coronary artery disease No myocardial infarction severe/unstable angina within past 6 month No severe peripheral vascular disease associate diabetes mellitus No deep venous arterial thrombosis within past 3 month No unstable cardiac rhythm No cerebrovascular accident within past 6 month Pulmonary : No pulmonary embolism within past 3 month Other : No history allergic reaction paclitaxel No active malignancy except : Basal cell squamous cell skin cancer Carcinoma situ cervix Synchronous epidermoid/squamous cell carcinoma head neck ( oral cavity , lip , hypopharynx , oropharynx , nasopharynx , sinonasal tract , larynx ) Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No active bacterial infection require antibiotic No concurrent medical condition would increase risk PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics More 4 week since prior radiotherapy Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2002</verification_date>
	<keyword>squamous cell carcinoma skin</keyword>
	<keyword>recurrent skin cancer</keyword>
	<keyword>stage IV nasopharyngeal cancer</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>metastatic squamous neck cancer occult primary squamous cell carcinoma</keyword>
	<keyword>squamous cell carcinoma unknown primary</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent carcinoma unknown primary</keyword>
</DOC>